Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
OPERATING EXPENSES
Research and development expenses	$ 60,204	$ 41,746	$ 88,550	$ 64,943
General and administrative expenses	341,199	236,479	753,261	739,884
Total operating expenses	401,403	278,225	841,811	804,827
LOSS FROM OPERATIONS	(401,403)	(278,225)	(841,811)	(804,827)
LOSS, BEFORE TAX	(401,403)	(278,225)	(841,811)	(804,827)
NET LOSS	$ (401,403)	$ (278,225)	$ (841,811)	$ (804,827)
Net loss per share attributable to common stockholders, basic	$ (0.02)	$ (0.02)	$ (0.06)	$ (0.07)
Net loss per share attributable to common stockholders, diluted	$ (0.02)	$ (0.02)	$ (0.06)	$ (0.07)
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, basic	16,072,267	11,346,535	14,407,244	11,346,535
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted	16,072,267	11,346,535	14,407,244	11,346,535